Article info

Download PDFPDF
Randomised controlled trial
Cessation of donepezil is associated with clinical decline in patients with moderate-to-severe Alzheimer's disease compared to continuation of donepezil or addition or substitution of memantine

Authors

  1. Correspondence to: Pierre N Tariot
    Banner Alzheimer's Institute, 901 E Willetta ST, Phoenix, Arizona 85006, USA; Pierre.tariot{at}bannerhealth.com
View Full Text

Citation

Tariot PN
Cessation of donepezil is associated with clinical decline in patients with moderate-to-severe Alzheimer's disease compared to continuation of donepezil or addition or substitution of memantine

Publication history

  • First published June 26, 2012.
Online issue publication 
July 20, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.